Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
5
Bullish
4
Bearish
5
Neutral
5
Bullish
36
Bearish
0
Neutral
0
Bullish
32
Bearish
5
Neutral
5
Bullish
4
Bearish
5
Neutral
5
Bullish
4
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Amwill Health Care Ltd is a derma-cosmetic company specializing in dermatological, cosmeceutical, and aesthetic products. It focuses on product formulation and development, outsourcing manufacturing and distribution to third-party agencies to streamline operations.
The company plans to raise capital through an Initial Public Offering, offering 62,00,000 equity shares, which includes a fresh issue of 50,00,000 shares and an offer for sale of 12,00,000 shares.
Their product portfolio is categorized into generic dermatological solutions and specific problem-solving drugs, reflecting a strategic focus on dermatological innovation.
Key products include XL-HYDRA, a facial moisturizer, and Fin-XL Pro Gel, a hair-care product, signifying their commitment to developing diverse personal care solutions.
Amwill Health Care has partnered with Amderma Healthcare LLP for a structured storage and distribution chain, highlighting their focus on efficient supply chain management.
Pharmaceuticals & Biotechnology
Pharmaceuticals
90 Cr
Moderate Risk
7.9
34.8
0.2
1.1
57.00
28.91
Sales CAGR
Profit CAGR
ROE
ROCE
Amwill Health Care Ltd (AMWILL) is currently trading at 44.99 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Amwill Health Care Ltd is a derma-cosmetic company specializing in dermatological, cosmeceutical, and aesthetic products. It focuses on product formulation and development, outsourcing manufacturing and distribution to third-party agencies to streamline operations. The company plans to raise capital through an Initial Public Offering, offering 62,00,000 equity shares, which includes a fresh issue of 50,00,000 shares and an offer for sale of 12,00,000 shares. Their product portfolio is categorized into generic dermatological solutions and specific problem-solving drugs, reflecting a strategic focus on dermatological innovation. Key products include XL-HYDRA, a facial moisturizer, and Fin-XL Pro Gel, a hair-care product, signifying their commitment to developing diverse personal care solutions. Amwill Health Care has partnered with Amderma Healthcare LLP for a structured storage and distribution chain, highlighting their focus on efficient supply chain management.
Over the past 52 weeks, Amwill Health Care Ltd has traded between a low of ₹28.91 and a high of ₹57.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Amwill Health Care Ltd has a market capitalization of approximately 90.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Amwill Health Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 7.88 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 90.00 Cr, Amwill Health Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Amwill Health Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Amwill Health Care Ltd is 7.88. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The company has informed BSE that its board meeting is scheduled for October 23, 2026 to consider and approve unaudited results for the half year ended September 30, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
136.40 | 94 Cr | — | 20.42 | 0.00 | 67.65 | -85.76 | -4.24 | ||
6.87 | 93 Cr | 20.82 | 1.19 | 0.00 | 6.03 | 8.35 | 3.45 | ||
44.99 | 90 Cr | 7.88 | 1.12 | 1.11 | 13.48 | 18.36 | 12.76 | ||
68.06 | 90 Cr | 43.63 | 1.92 | 0.00 | 2.17 | 5.12 | 2.74 | ||
731.05 | 88 Cr | 19.98 | 1.51 | 0.48 | 8.32 | 10.75 | 5.27 | ||
277.50 | 86 Cr | — | 1.26 | 0.00 | -4.86 | -2.57 | -1.78 | ||
60.00 | 83 Cr | 10.43 | 0.91 | 4.17 | 9.18 | 13.14 | 6.39 | ||
| Median: 7 Co. | — | 68.06 | 90 Cr | 19.98 | 1.26 | 0.00 | 8.32 | 8.35 | 3.45 |
